Among its stipulations, the FDA Modernization Act would allow researchers to use the most accurate model systems when assessing a new compound’s safety, eliminating the requirement that all drugs be tested in animals before clinical trials.
Groups like Animal Wellness Action are pushing lawmakers to pass the FDA Modernization Act. The bill allows an applicant for market approval for a new drug to use methods other than animal testing to establish the drug’s safety and effectiveness.
Animal testing isn’t just ethically questionable — it’s actually not that effective. Several biotech firms are developing technology that could change that.
A growing body of evidence suggests that animal models are seriously lacking in both sensitivity and specificity when it comes to predicting drug toxicity in humans.
New advancements in computer modeling, tissue engineering and other bio-convergence technologies have made the need to test on animals obsolete.
This past week, a handful of bipartisan lawmakers introduced two bills aimed at ending one of our nation’s most-barbaric practices — mandatory animal testing of new pharmaceuticals destined for human trials.
At the hearing before the House Energy and Commerce Health Subcommittee on the FDA Modernization Act, Congressmen Kurt Schrader and Tony Cardenas spoke in favor of the landmark bill, which now has 40 Democrat and 35 Republican cosponsors in the House and more than 125 endorsing organizations, including major medical associations, biotech companies, and even some major pharmaceutical companies.